{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:19:09Z","timestamp":1793683149035,"version":"4.5.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12917-015-0546-y","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T20:55:56Z","timestamp":1442264156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors"],"prefix":"10.1186","volume":"11","author":[{"given":"Mich\u00e8le","family":"Spoerri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Guscetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Hartnack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alois","family":"Boos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata M","family":"Nowaczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris M","family":"Reichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz P","family":"Kowalewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,15]]},"reference":[{"issue":"2","key":"546_CR1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1097-0029(20010115)52:2<155::AID-JEMT1001>3.0.CO;2-P","volume":"52","author":"GB Silberstein","year":"2001","unstructured":"Silberstein GB. Postnatal mammary gland morphogenesis. Microsc Res Tech. 2001;52(2):155\u201362. doi: 10.1002\/1097-0029(20010115)52:2<155::AID-JEMT1001>3.0.CO;2-P .","journal-title":"Microsc Res Tech"},{"issue":"1","key":"546_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0300985810389480","volume":"48","author":"KU Sorenmo","year":"2010","unstructured":"Sorenmo KU, Rasotto R, Zappulli V, Goldschmidt MH. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms. Vet Pathol. 2010;48(1):85\u201397. doi: 10.1177\/0300985810389480 .","journal-title":"Vet Pathol"},{"issue":"1","key":"546_CR3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/dbio.1999.9271","volume":"210","author":"C Brisken","year":"1999","unstructured":"Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, et al. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol. 1999;210(1):96\u2013106. doi: 10.1006\/dbio.1999.9271 .","journal-title":"Dev Biol"},{"issue":"1","key":"546_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2001-0036","volume":"24","author":"CV Clevenger","year":"2003","unstructured":"Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev. 2003;24(1):1\u201327.","journal-title":"Endocr Rev"},{"issue":"3","key":"546_CR5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/bdrb.20121","volume":"80","author":"S Rehm","year":"2007","unstructured":"Rehm S, Stanislaus DJ, Williams AM. Estrous cycle-dependent histology and review of sex steroid receptor expression in dog reproductive tissues and mammary gland and associated hormone levels. Birth Defects Res B Dev Reprod Toxicol. 2007;80(3):233\u201345. doi: 10.1002\/bdrb.20121 .","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"6","key":"546_CR6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/0192623310374327","volume":"38","author":"SA Chandra","year":"2010","unstructured":"Chandra SA, Mark Cline J, Adler RR. Cyclic morphological changes in the beagle mammary gland. Toxicol Pathol. 2010;38(6):969\u201383. doi: 10.1177\/0192623310374327 .","journal-title":"Toxicol Pathol"},{"issue":"1\u20132","key":"546_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0303-7207(02)00259-9","volume":"197","author":"E Garderen van","year":"2002","unstructured":"van Garderen E, Schalken JA. Morphogenic and tumorigenic potentials of the mammary growth hormone\/growth hormone receptor system. Mol Cell Endocrinol. 2002;197(1\u20132):153\u201365. doi: 10.1016\/S0303-7207(02)00259-9 .","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"546_CR8","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1210\/endo.140.12.7189","volume":"140","author":"E Garderen van","year":"1999","unstructured":"van Garderen E, van der Poel HJ, Swennenhuis JF, Wissink EH, Rutteman GR, Hellmen E, et al. Expression and molecular characterization of the growth hormone receptor in canine mammary tissue and mammary tumors. Endocrinology. 1999;140(12):5907\u201314. doi: 10.1210\/endo.140.12.7189 .","journal-title":"Endocrinology"},{"issue":"6","key":"546_CR9","first-page":"1249","volume":"43","author":"R Schneider","year":"1969","unstructured":"Schneider R, Dorn CR, Taylor DO. Factors influencing canine mammary cancer development and postsurgical survival. J Natl Cancer Inst. 1969;43(6):1249\u201361.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"546_CR10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1748-5827.2011.01220.x","volume":"53","author":"W Beauvais","year":"2012","unstructured":"Beauvais W, Cardwell JM, Brodbelt DC. The effect of neutering on the risk of mammary tumours in dogs-a systematic review. J Small Anim Pract. 2012;53(6):314\u201322. doi: 10.1111\/j.1748-5827.2011.01220.x .","journal-title":"J Small Anim Pract"},{"issue":"4","key":"546_CR11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/jvim.12110","volume":"27","author":"VM Kristiansen","year":"2013","unstructured":"Kristiansen VM, Nodtvedt A, Breen AM, Langeland M, Teige J, Goldschmidt M, et al. Effect of ovariohysterectomy at the time of tumor removal in dogs with benign mammary tumors and hyperplastic lesions: a randomized controlled clinical trial. J Vet Intern Med. 2013;27(4):935\u201342. doi: 10.1111\/jvim.12110 .","journal-title":"J Vet Intern Med"},{"issue":"10","key":"546_CR12","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2460\/javma.2005.227.1625","volume":"227","author":"SC Chang","year":"2005","unstructured":"Chang SC, Chang CC, Chang TJ, Wong ML. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998\u20132002). J Am Vet Med Assoc. 2005;227(10):1625\u20139.","journal-title":"J Am Vet Med Assoc"},{"issue":"3","key":"546_CR13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1939-1676.2000.tb01165.x","volume":"14","author":"KU Sorenmo","year":"2000","unstructured":"Sorenmo KU, Shofer FS, Goldschmidt MH. Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J Vet Intern Med. 2000;14(3):266\u201370.","journal-title":"J Vet Intern Med"},{"issue":"10","key":"546_CR14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1748-5827.1996.tb01740.x","volume":"37","author":"T Yamagami","year":"1996","unstructured":"Yamagami T, Kobayashi T, Takahashi K, Sugiyama M. Influence of ovariectomy at the time of mastectomy on the prognosis for canine malignant mammary tumours. J Small Anim Pract. 1996;37(10):462\u20134.","journal-title":"J Small Anim Pract"},{"issue":"1","key":"546_CR15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1939-1676.2003.tb01330.x","volume":"17","author":"JC Philibert","year":"2003","unstructured":"Philibert JC, Snyder PW, Glickman N, Glickman LT, Knapp DW, Waters DJ. Influence of host factors on survival in dogs with malignant mammary gland tumors. J Vet Intern Med. 2003;17(1):102\u20136.","journal-title":"J Vet Intern Med"},{"issue":"7","key":"546_CR16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.steroids.2005.11.007","volume":"71","author":"JC Illera","year":"2006","unstructured":"Illera JC, Perez-Alenza MD, Nieto A, Jimenez MA, Silvan G, Dunner S, et al. Steroids and receptors in canine mammary cancer. Steroids. 2006;71(7):541\u20138. doi: 10.1016\/j.steroids.2005.11.007 .","journal-title":"Steroids"},{"issue":"1\u20133","key":"546_CR17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jsbmb.2004.12.014","volume":"94","author":"FL Queiroga","year":"2005","unstructured":"Queiroga FL, Perez-Alenza MD, Silvan G, Pena L, Lopes C, Illera JC. Role of steroid hormones and prolactin in canine mammary cancer. J Steroid Biochem Mol Biol. 2005;94(1\u20133):181\u20137. doi: 10.1016\/j.jsbmb.2004.12.014 .","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3\u20135","key":"546_CR18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2007.03.014","volume":"104","author":"AR Sanchez-Archidona","year":"2007","unstructured":"Sanchez-Archidona AR, Jimenez MA, Perez-Alenza D, Silvan G, Illera JC, Pena L, et al. Steroid pathway and oestrone sulphate production in canine inflammatory mammary carcinoma. J Steroid Biochem Mol Biol. 2007;104(3\u20135):93\u20139. doi: 10.1016\/j.jsbmb.2007.03.014 .","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"546_CR19","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/jnci\/60.6.1351","volume":"60","author":"RC Giles","year":"1978","unstructured":"Giles RC, Kwapien RP, Geil RG, Casey HW. Mammary nodules in beagle dogs administered investigational oral contraceptive steroids. J Natl Cancer Inst. 1978;60(6):1351\u201364.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"546_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0015-0282(16)45741-9","volume":"36","author":"PW Concannon","year":"1981","unstructured":"Concannon PW, Spraker TR, Casey HW, Hansel W. Gross and histopathologic effects of medroxyprogesterone acetate and progesterone on the mammary glands of adult beagle bitches. Fertil Steril. 1981;36(3):373\u201387.","journal-title":"Fertil Steril"},{"issue":"8","key":"546_CR21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1699-0463.1997.tb05057.x","volume":"105","author":"M Stovring","year":"1997","unstructured":"Stovring M, Moe L, Glattre E. A population-based case\u2013control study of canine mammary tumours and clinical use of medroxyprogesterone acetate. APMIS. 1997;105(8):590\u20136.","journal-title":"APMIS"},{"issue":"1","key":"546_CR22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1210\/endo.134.1.7506206","volume":"134","author":"PJ Selman","year":"1994","unstructured":"Selman PJ, Mol JA, Rutteman GR, van Garderen E, Rijnberk A. Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology. 1994;134(1):287\u201392. doi: 10.1210\/endo.134.1.7506206 .","journal-title":"Endocrinology"},{"issue":"16","key":"546_CR23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/vr.102263","volume":"175","author":"FL Queiroga","year":"2014","unstructured":"Queiroga FL, Perez-Alenza MD, Gonzalez Gil A, Silvan G, Pena L, Illera JC. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours. Vet Rec. 2014;175(16):403. doi: 10.1136\/vr.102263 .","journal-title":"Vet Rec"},{"issue":"2","key":"546_CR24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1354\/vp.42-2-200","volume":"42","author":"JM Las Mulas de","year":"2005","unstructured":"de Las Mulas JM, Millan Y, Dios R. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Vet Pathol. 2005;42(2):200\u201312. doi: 10.1354\/vp.42-2-200 .","journal-title":"Vet Pathol"},{"key":"546_CR25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1746-6148-8-72","volume":"8","author":"E Michel","year":"2012","unstructured":"Michel E, Feldmann SK, Kowalewski MP, Bley CR, Boos A, Guscetti F, et al. Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas. BMC Vet Res. 2012;8:72. doi: 10.1186\/1746-6148-8-72 .","journal-title":"BMC Vet Res"},{"issue":"14","key":"546_CR26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/vr.146.14.403","volume":"146","author":"M Geraldes","year":"2000","unstructured":"Geraldes M, Gartner F, Schmitt F. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours. Vet Rec. 2000;146(14):403\u20136.","journal-title":"Vet Rec"},{"issue":"5","key":"546_CR27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/bjc.1988.266","volume":"58","author":"GR Rutteman","year":"1988","unstructured":"Rutteman GR, Misdorp W, Blankenstein MA, van den Brom WE. Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states. Br J Cancer. 1988;58(5):594\u20139.","journal-title":"Br J Cancer"},{"issue":"4","key":"546_CR28","first-page":"829","volume":"6","author":"GR Rutteman","year":"1986","unstructured":"Rutteman GR, Willekes-Koolschijn N, Bevers MM, Van der Gugten AA, Misdorp W. Prolactin binding in benign and malignant mammary tissue of female dogs. Anticancer Res. 1986;6(4):829\u201335.","journal-title":"Anticancer Res"},{"issue":"3","key":"546_CR29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.rvsc.2005.02.002","volume":"79","author":"F Millanta","year":"2005","unstructured":"Millanta F, Calandrella M, Bari G, Niccolini M, Vannozzi I, Poli A. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Res Vet Sci. 2005;79(3):225\u201332. doi: 10.1016\/j.rvsc.2005.02.002 .","journal-title":"Res Vet Sci"},{"issue":"4","key":"546_CR30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2460\/javma.235.4.391","volume":"235","author":"CC Chang","year":"2009","unstructured":"Chang CC, Tsai MH, Liao JW, Chan JP, Wong ML, Chang SC. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors. J Am Vet Med Assoc. 2009;235(4):391\u20136. doi: 10.2460\/javma.235.4.391 .","journal-title":"J Am Vet Med Assoc"},{"issue":"3","key":"546_CR31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1354\/vp.37-3-239","volume":"37","author":"A Nieto","year":"2000","unstructured":"Nieto A, Pena L, Perez-Alenza MD, Sanchez MA, Flores JM, Castano M. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol. 2000;37(3):239\u201347.","journal-title":"Vet Pathol"},{"issue":"1","key":"546_CR32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1476-5829.2011.00269.x","volume":"10","author":"KM Pawlowski","year":"2012","unstructured":"Pawlowski KM, Popielarz D, Szyszko K, Gajewska M, Motyl T, Krol M. Growth hormone receptor (GHR) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line. Vet Comp Oncol. 2012;10(1):2\u201315. doi: 10.1111\/j.1476-5829.2011.00269.x .","journal-title":"Vet Comp Oncol"},{"issue":"3","key":"546_CR33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1939-1676.2011.0723.x","volume":"25","author":"S Guil-Luna","year":"2011","unstructured":"Guil-Luna S, Sanchez-Cespedes R, Millan Y, De Andres FJ, Rollon E, Domingo V, et al. Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas. J Vet Intern Med. 2011;25(3):518\u201323. doi: 10.1111\/j.1939-1676.2011.0723.x .","journal-title":"J Vet Intern Med"},{"issue":"7","key":"546_CR34","first-page":"949","volume":"29","author":"S Guil-Luna","year":"2014","unstructured":"Guil-Luna S, Hellmen E, Sanchez-Cespedes R, Millan Y, Martin De Las Mulas J. The antiprogestins mifepristone and onapristone reduce cell proliferation in the canine mammary carcinoma cell line CMT-U27. Histol Histopathol. 2014;29(7):949\u201355. doi:HH-11-454.","journal-title":"Histol Histopathol"},{"issue":"3","key":"546_CR35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2217\/whe.10.25","volume":"6","author":"R Stuart-Harris","year":"2010","unstructured":"Stuart-Harris R, Davis A. Optimal adjuvant endocrine therapy for early breast cancer. Womens Health (Lond Engl). 2010;6(3):383\u201398. doi: 10.2217\/whe.10.25 .","journal-title":"Womens Health (Lond Engl)"},{"issue":"26","key":"546_CR36","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJM198812293192601","volume":"319","author":"EBCTC Group","year":"1988","unstructured":"Group EBCTC. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists\u2019 Collaborative Group. N Engl J Med. 1988;319(26):1681\u201392. doi: 10.1056\/NEJM198812293192601 .","journal-title":"N Engl J Med"},{"issue":"5 Pt 2","key":"546_CR37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0029-7844(00)01196-0","volume":"97","author":"MJ Mourits","year":"2001","unstructured":"Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG. Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol. 2001;97(5 Pt 2):855\u201366. doi:S0029784400011960.","journal-title":"Obstet Gynecol"},{"issue":"22","key":"546_CR38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/vr.133.22.539","volume":"133","author":"JS Morris","year":"1993","unstructured":"Morris JS, Dobson JM, Bostock DE. Use of tamoxifen in the control of canine mammary neoplasia. Vet Rec. 1993;133(22):539\u201342.","journal-title":"Vet Rec"},{"key":"546_CR39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1751-0147-52-67","volume":"52","author":"WL Tavares","year":"2010","unstructured":"Tavares WL, Lavalle GE, Figueiredo MS, Souza AG, Bertagnolli AC, Viana FA, et al. Evaluation of adverse effects in tamoxifen exposed healthy female dogs. Acta Vet Scand. 2010;52:67. doi: 10.1186\/1751-0147-52-67 .","journal-title":"Acta Vet Scand"},{"key":"546_CR40","volume-title":"Prolactin and anti-prolactin agents in the pathophysiology and treatment of mammary tumors in the dog","author":"JP Verstegen","year":"2006","unstructured":"Verstegen JP, Onclin K. Prolactin and anti-prolactin agents in the pathophysiology and treatment of mammary tumors in the dog. Orlando, FL: The North American Vetrinary Conference; 2006."},{"issue":"2","key":"546_CR41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5301\/jbm.5000027","volume":"28","author":"EM Foo","year":"2013","unstructured":"Foo EM, Boost MV, Wong AS, Loo WT, Chow LW, Chow CY. New developments in breast cancer prognosis: molecular predictors of treatment response and survival. Int J Biol Markers. 2013;28(2):131\u201340. doi: 10.5301\/jbm.5000027 .","journal-title":"Int J Biol Markers"},{"issue":"1","key":"546_CR42","first-page":"19","volume":"16","author":"N Guriec","year":"1996","unstructured":"Guriec N, Marcellin L, Gairard B, Calderoli H, Wilk A, Renaud R, et al. E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival. Invasion Metastasis. 1996;16(1):19\u201326.","journal-title":"Invasion Metastasis"},{"issue":"1","key":"546_CR43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2559.1999.00540.x","volume":"34","author":"A Bankfalvi","year":"1999","unstructured":"Bankfalvi A, Terpe HJ, Breukelmann D, Bier B, Rempe D, Pschadka G, et al. Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Histopathology. 1999;34(1):25\u201334.","journal-title":"Histopathology"},{"issue":"9","key":"546_CR44","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0959-8049(00)00062-9","volume":"36","author":"KS Asgeirsson","year":"2000","unstructured":"Asgeirsson KS, Jonasson JG, Tryggvadottir L, Olafsdottir K, Sigurgeirsdottir JR, Ingvarsson S, et al. Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance. Eur J Cancer. 2000;36(9):1098\u2013106. doi:S0959804900000629.","journal-title":"Eur J Cancer"},{"issue":"2","key":"546_CR45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0021-9975(97)80076-X","volume":"116","author":"B Restucci","year":"1997","unstructured":"Restucci B, Papparella S, De Vico G, Maiolino P. E cadherin expression in normal and neoplastic canine mammary gland. J Comp Pathol. 1997;116(2):191\u2013202.","journal-title":"J Comp Pathol"},{"issue":"20","key":"546_CR46","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/vr.152.20.621","volume":"152","author":"AL Reis","year":"2003","unstructured":"Reis AL, Carvalheira J, Schmitt FC, Gartner F. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours. Vet Rec. 2003;152(20):621\u20134.","journal-title":"Vet Rec"},{"issue":"1","key":"546_CR47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tvjl.2007.05.024","volume":"177","author":"A Gama","year":"2008","unstructured":"Gama A, Paredes J, Gartner F, Alves A, Schmitt F. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Vet J. 2008;177(1):45\u201353. doi: 10.1016\/j.tvjl.2007.05.024 .","journal-title":"Vet J"},{"issue":"2\u20133","key":"546_CR48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jcpa.2005.10.004","volume":"134","author":"AJ Matos","year":"2006","unstructured":"Matos AJ, Lopes C, Carvalheira J, Santos M, Rutteman GR, Gartner F. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables. J Comp Pathol. 2006;134(2\u20133):182\u20139. doi: 10.1016\/j.jcpa.2005.10.004 .","journal-title":"J Comp Pathol"},{"issue":"3","key":"546_CR49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1439-0531.2003.00432.x","volume":"38","author":"Y Corrada","year":"2003","unstructured":"Corrada Y, Castex G, Sosa Y, Gobello C. Secretory patterns of prolactin in dogs: circannual and ultradian rhythms. Reprod Domest Anim. 2003;38(3):219\u201323. doi: 10.1046\/j.1439-0531.2003.00432.x .","journal-title":"Reprod Domest Anim"},{"issue":"1","key":"546_CR50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1439-0531.2001.00221.x","volume":"36","author":"C Gobello","year":"2001","unstructured":"Gobello C, Bolognani F, de la Sota RL, Goya RG. Twenty-four-hour profiles of serum prolactin and luteinizing hormone in anoestrous crossbred bitches. Reprod Domest Anim. 2001;36(1):41\u20135.","journal-title":"Reprod Domest Anim"},{"issue":"3","key":"546_CR51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/01652176.1985.9693978","volume":"7","author":"AC Okkens","year":"1985","unstructured":"Okkens AC, Dieleman SJ, Bevers MM, Willemse AH. Evidence for the non-involvement of the uterus in the lifespan of the corpus luteum in the cyclic dog. Vet Q. 1985;7(3):169\u201373. doi: 10.1080\/01652176.1985.9693978 .","journal-title":"Vet Q"},{"issue":"2","key":"546_CR52","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/jrf.0.0810533","volume":"81","author":"SJ Dieleman","year":"1987","unstructured":"Dieleman SJ, Bevers MM. Effects of monoclonal antibody against PMSG administered shortly after the preovulatory LH surge on time and number of ovulations in PMSG\/PG-treated cows. J Reprod Fertil. 1987;81(2):533\u201342.","journal-title":"J Reprod Fertil"},{"issue":"1","key":"546_CR53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/jrf.0.1010221","volume":"101","author":"B Haaften van","year":"1994","unstructured":"van Haaften B, Bevers MM, van den Brom WE, Okkens AC, van Sluijs FJ, Willemse AH, et al. Increasing sensitivity of the pituitary to GnRH from early to late anoestrus in the beagle bitch. J Reprod Fertil. 1994;101(1):221\u20135.","journal-title":"J Reprod Fertil"},{"issue":"4","key":"546_CR54","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0016-6480(79)90242-9","volume":"39","author":"SJ Dieleman","year":"1979","unstructured":"Dieleman SJ, Schoenmakers HJ. Radioimmunoassays to determine the presence of progesterone and estrone in the starfish Asterias rubens. Gen Comp Endocrinol. 1979;39(4):534\u201342.","journal-title":"Gen Comp Endocrinol"},{"issue":"1","key":"546_CR55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/0300985810393258","volume":"48","author":"M Goldschmidt","year":"2011","unstructured":"Goldschmidt M, Pena L, Rasotto R, Zappulli V. Classification and grading of canine mammary tumors. Vet Pathol. 2011;48(1):117\u201331. doi: 10.1177\/0300985810393258 .","journal-title":"Vet Pathol"},{"issue":"6\u20137","key":"546_CR56","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.theriogenology.2006.01.039","volume":"66","author":"MP Kowalewski","year":"2006","unstructured":"Kowalewski MP, Schuler G, Taubert A, Engel E, Hoffmann B. Expression of cyclooxygenase 1 and 2 in the canine corpus luteum during diestrus. Theriogenology. 2006;66(6\u20137):1423\u201330. doi: 10.1016\/j.theriogenology.2006.01.039 .","journal-title":"Theriogenology"},{"issue":"5","key":"546_CR57","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.theriogenology.2010.10.030","volume":"75","author":"MP Kowalewski","year":"2011","unstructured":"Kowalewski MP, Meyer A, Hoffmann B, Aslan S, Boos A. Expression and functional implications of peroxisome proliferator-activated receptor gamma (PPARgamma) in canine reproductive tissues during normal pregnancy and parturition and at antiprogestin induced abortion. Theriogenology. 2011;75(5):877\u201386. doi: 10.1016\/j.theriogenology.2010.10.030 .","journal-title":"Theriogenology"},{"key":"546_CR58","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2013","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013. http:\/\/www.R-project.org\/ ."},{"key":"546_CR59","unstructured":"Pinheiro J, Bates D, DebRoby S, Sarkar D. Linear and nonlinear mixed effects models, 2010, R package version 3.1-97. R package version 31\u201397. 2010."},{"issue":"2","key":"546_CR60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0753-3322(01)00157-3","volume":"56","author":"LC Murphy","year":"2002","unstructured":"Murphy LC, Watson P. Steroid receptors in human breast tumorigenesis and breast cancer progression. Biomed Pharmacother. 2002;56(2):65\u201377.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"546_CR61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1018718117113","volume":"3","author":"E Anderson","year":"1998","unstructured":"Anderson E, Clarke RB, Howell A. Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia. 1998;3(1):23\u201335.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"3","key":"546_CR62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/edrv.19.3.0334","volume":"19","author":"C Bole-Feysot","year":"1998","unstructured":"Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998;19(3):225\u201368.","journal-title":"Endocr Rev"},{"key":"546_CR63","doi-asserted-by":"crossref","unstructured":"Mainenti M, Rasotto R, Carnier P, Zappulli V. Oestrogen-alpha and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs. Vet J. 2014. doi: 10.1016\/j.tvjl.2014.06.003 .","DOI":"10.1016\/j.tvjl.2014.06.003"},{"issue":"1","key":"546_CR64","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/0300985810390826","volume":"48","author":"R Klopfleisch","year":"2010","unstructured":"Klopfleisch R, von Euler H, Sarli G, Pinho SS, Gartner F, Gruber AD. Molecular carcinogenesis of canine mammary tumors: news from an old disease. Vet Pathol. 2010;48(1):98\u2013116. doi: 10.1177\/0300985810390826 .","journal-title":"Vet Pathol"},{"issue":"3","key":"546_CR65","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0195-5616(85)50053-4","volume":"15","author":"HR Ferguson","year":"1985","unstructured":"Ferguson HR. Canine mammary gland tumors. Vet Clin North Am Small Anim Pract. 1985;15(3):501\u201311.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"3","key":"546_CR66","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1476-5829.2009.00184.x","volume":"7","author":"KU Sorenmo","year":"2009","unstructured":"Sorenmo KU, Kristiansen VM, Cofone MA, Shofer FS, Breen AM, Langeland M, et al. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Vet Comp Oncol. 2009;7(3):162\u201372. doi: 10.1111\/j.1476-5829.2009.00184.x .","journal-title":"Vet Comp Oncol"},{"issue":"3","key":"546_CR67","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/030098587401100303","volume":"11","author":"EH Fowler","year":"1974","unstructured":"Fowler EH, Wilson GP, Koestner A. Biologic behavior of canine mammary neoplasms based on a histogenetic classification. Vet Pathol. 1974;11(3):212\u201329.","journal-title":"Vet Pathol"},{"key":"546_CR68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/BD-2003-18108","volume":"18","author":"CV Clevenger","year":"2003","unstructured":"Clevenger CV. Role of prolactin\/prolactin receptor signaling in human breast cancer. Breast Dis. 2003;18:75\u201386.","journal-title":"Breast Dis"},{"issue":"7","key":"546_CR69","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1158\/0008-5472.CAN-08-4033","volume":"69","author":"A Plotnikov","year":"2009","unstructured":"Plotnikov A, Varghese B, Tran TH, Liu C, Rui H, Fuchs SY. Impaired turnover of prolactin receptor contributes to transformation of human breast cells. Cancer Res. 2009;69(7):3165\u201372. doi: 10.1158\/0008-5472.CAN-08-4033 .","journal-title":"Cancer Res"},{"issue":"13","key":"546_CR70","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/sj.onc.1209214","volume":"25","author":"Y Li","year":"2006","unstructured":"Li Y, Clevenger CV, Minkovsky N, Kumar KG, Raghunath PN, Tomaszewski JE, et al. Stabilization of prolactin receptor in breast cancer cells. Oncogene. 2006;25(13):1896\u2013902. doi: 10.1038\/sj.onc.1209214 .","journal-title":"Oncogene"},{"issue":"12","key":"546_CR71","first-page":"2591","volume":"55","author":"E Ginsburg","year":"1995","unstructured":"Ginsburg E, Vonderhaar BK. Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 1995;55(12):2591\u20135.","journal-title":"Cancer Res"},{"issue":"12","key":"546_CR72","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/endo.138.12.5605","volume":"138","author":"C Reynolds","year":"1997","unstructured":"Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV. Expression of prolactin and its receptor in human breast carcinoma. Endocrinology. 1997;138(12):5555\u201360. doi: 10.1210\/endo.138.12.5605 .","journal-title":"Endocrinology"},{"key":"546_CR73","doi-asserted-by":"crossref","unstructured":"Harvey S, Martinez-Moreno CG, Luna M, Aramburo C. Autocrine\/paracrine roles of extrapituitary growth hormone and prolactin in health and disease: An overview. Gen Comp Endocrinol. 2014. doi: 10.1016\/j.ygcen.2014.11.004 .","DOI":"10.1016\/j.ygcen.2014.11.004"},{"issue":"3","key":"546_CR74","first-page":"695","volume":"146","author":"CV Clevenger","year":"1995","unstructured":"Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT, Tomaszewski JE. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine\/paracrine loop. Am J Pathol. 1995;146(3):695\u2013705.","journal-title":"Am J Pathol"},{"issue":"2","key":"546_CR75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1476-5829.2012.00337.x","volume":"12","author":"E Michel","year":"2014","unstructured":"Michel E, Rohrer Bley C, Kowalewski MP, Feldmann SK, Reichler IM. Prolactin--to be reconsidered in canine mammary tumourigenesis? Vet Comp Oncol. 2014;12(2):93\u2013105. doi: 10.1111\/j.1476-5829.2012.00337.x .","journal-title":"Vet Comp Oncol"},{"issue":"2","key":"546_CR76","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1349-7006.2007.00685.x","volume":"99","author":"AS Sultan","year":"2008","unstructured":"Sultan AS, Brim H, Sherif ZA. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition. Cancer Sci. 2008;99(2):272\u20139. doi: 10.1111\/j.1349-7006.2007.00685.x .","journal-title":"Cancer Sci"},{"issue":"5","key":"546_CR77","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/sj.onc.1208203","volume":"24","author":"AS Sultan","year":"2005","unstructured":"Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene. 2005;24(5):746\u201360. doi: 10.1038\/sj.onc.1208203 .","journal-title":"Oncogene"},{"issue":"11","key":"546_CR78","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1200\/JCO.2004.11.046","volume":"22","author":"MT Nevalainen","year":"2004","unstructured":"Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, et al. Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol. 2004;22(11):2053\u201360. doi: 10.1200\/JCO.2004.11.046 .","journal-title":"J Clin Oncol"},{"issue":"3","key":"546_CR79","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/0008-5472.CAN-05-2292","volume":"66","author":"Z Nouhi","year":"2006","unstructured":"Nouhi Z, Chughtai N, Hartley S, Cocolakis E, Lebrun JJ, Ali S. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells. Cancer Res. 2006;66(3):1824\u201332. doi: 10.1158\/0008-5472.CAN-05-2292 .","journal-title":"Cancer Res"},{"issue":"1","key":"546_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.1772","volume":"32","author":"PW Harvey","year":"2012","unstructured":"Harvey PW. Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific. J Appl Toxicol. 2012;32(1):1\u20139. doi: 10.1002\/jat.1772 .","journal-title":"J Appl Toxicol"},{"key":"546_CR81","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1017\/S0022029905001196","volume":"72","author":"C Manhes","year":"2005","unstructured":"Manhes C, Goffin V, Kelly PA, Touraine P. Autocrine prolactin as a promotor of mammary tumour growth. J Dairy Res. 2005;72:58\u201365.","journal-title":"J Dairy Res"},{"issue":"4","key":"546_CR82","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/mend.16.4.0817","volume":"16","author":"JL Brockman","year":"2002","unstructured":"Brockman JL, Schroeder MD, Schuler LA. PRL activates the cyclin D1 promoter via the Jak2\/Stat pathway. Mol Endocrinol. 2002;16(4):774\u201384. doi: 10.1210\/mend.16.4.0817 .","journal-title":"Mol Endocrinol"},{"issue":"4","key":"546_CR83","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-0463.2007.apm_544.x","volume":"115","author":"AJ Matos De","year":"2007","unstructured":"De Matos AJ, Lopes CC, Faustino AM, Carvalheira JG, Rutteman GR, Gartner MF. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours. APMIS. 2007;115(4):327\u201334. doi: 10.1111\/j.1600-0463.2007.apm_544.x .","journal-title":"APMIS"},{"key":"546_CR84","volume-title":"Relative expression of CDH1 gene in mammary carcinoma in female dogs searching for correlations with ocular and thoracic metastasis","author":"LMC Pardini","year":"2014","unstructured":"Pardini LMC, Ranzani JJT, Brand\u00e3o CVS, Lopes C, Souza PM, Castillo JAL, et al. Relative expression of CDH1 gene in mammary carcinoma in female dogs searching for correlations with ocular and thoracic metastasis. Prague, Czech Republic: The World Congress on Controversies, Debates & Consensus in Veterinary Medicine (CoVet); 2014."},{"issue":"4","key":"546_CR85","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbrc.2009.01.024","volume":"379","author":"SS Pinho","year":"2009","unstructured":"Pinho SS, Osorio H, Nita-Lazar M, Gomes J, Lopes C, Gartner F, et al. Role of E-cadherin N-glycosylation profile in a mammary tumor model. Biochem Biophys Res Commun. 2009;379(4):1091\u20136. doi: 10.1016\/j.bbrc.2009.01.024 .","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"546_CR86","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1111\/j.1439-0531.2009.01550.x","volume":"45","author":"B Guo","year":"2010","unstructured":"Guo B, Han BC, Tian Z, Zhang XM, Jiang LX, Liu JX, et al. Expression and hormonal regulation of E-cadherin in canine uterus during early pregnancy. Reprod Domest Anim. 2010;45(6):e255\u20139. doi: 10.1111\/j.1439-0531.2009.01550.x .","journal-title":"Reprod Domest Anim"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-015-0546-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T10:38:53Z","timestamp":1567161533000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1746-6148\/11\/235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,15]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["546"],"URL":"https:\/\/doi.org\/10.1186\/s12917-015-0546-y","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,15]]},"article-number":"235"}}